Free ShippingOver $49
Call:877-500-9944
Fax:877-500-9950
My ProfileMy OrdersMy AutoShipMy RxMy PetsMy VetsMy RewardsSign In
Product Page

Osphos Inj 60mg/mL, 15 ml Rx

This Item Ships FREE!
Availability:

Please confirm

Close
This item is already on your autoship schedule! Are you sure you want to add it again?
Auto-Ship
Quantity
-
+

Product Overview

How To Use

What’s in it?

Reviews

Questions & Answers

Product Description

If your horse is having problems associated with navicular syndrome Osphos Inj 60 can help alleviate their symptoms and slow down the progression of the disease. Easy to use vials are ready to use and don't require any dilution.  
 
 
 

What is Osphos Inj 60mg/mL, 15 ml?

OSPHOS is an injectable bisphosphonate solution for the control of clinical signs associated with navicular syndrome in horses four years and older. OSPHOS inhibits bone resorption by binding to calcium phosphate crystals (inhibiting their formation and dissolution), and by exerting direct cellular effects on osteoclasts. OSPHOS is supplied as 15 mL (900 mg) of clodronate disodium (60 mg/mL) per vial and is ready-to-use (no reconstitution or dilution required).

Who is Osphos Inj 60mg/mL, 15 ml for?

Horses

Why use Osphos Inj 60mg/mL, 15 ml?

-For Horses (Equine) four years and older -Clodronate injection (60mg per mL) -The Only Intramuscular Option -- Injectable bisphosphonate solution for the control of clinical signs associated with navicular syndrome -When radiographic signs indicative of bony changes associated with navicular syndrome are present, OSPHOS is a clear choice. -OSPHOS inhibits bone resorption by binding to calcium phosphate crystals (inhibiting their formation and dissolution), and by exerting direct cellular effects on osteoclasts.

How does Osphos Inj 60mg/mL, 15 ml work?

OSPHOS inhibits bone resorption by binding to calcium phosphate crystals (inhibiting their formation and dissolution), and by exerting direct cellular effects on osteoclasts.

Manufacturer:

Dechra Pharmaceuticals

Active ingredient(s):

Osphos intramuscular injection contains the bisphosphonate Clodronic acid

How is Osphos Inj 60mg/mL, 15 ml sold?

Osphos Inj 60mg/mL is sold in 15ml - single use vial

What are the side effects of Osphos Inj 60mg/mL, 15 ml?

In field studies, the most common side effects reported were signs of discomfort or nervousness, cramping, pawing and/or colic within 2 hours post-treatment (9% of horses treated: n=10). Eight out of ten of these horses had resolution of their clinical signs with 10 to 15 minutes of hand walking. In one horse, clinical signs resolved without hand walking. Only one experienced colic requiring treatment. That horse also developed hives and recovered after treatment with flunixin and dexamethasone.

What special precautions are there?

Keep out of reach of children

What to do if overdose?

Contact your nearest emergency animal hospital

How can I store Osphos Inj 60mg/mL, 15 ml?

Store in a cool and dry place

Helpful Tips:

OSPHOS is administered at 1.8 mg/kg by intramuscular injection up to a maximum dose of 900 mg per horse (one vial). Divide the total volume evenly into three separate injection sites. Discard unused vial contents. OSPHOS is provided in a single use vial and does not contain a preservative. If there is no response to initial therapy, the horse should be re-evaluated. For horses that initially respond to OSPHOS but do not maintain their clinical improvement for 6 months, OSPHOS may be re-administered at 3 to 6 month intervals based on recurrence of clinical signs. For horses that respond to OSPHOS and maintain clinical improvement for 6 months, OSPHOS should be re-administered after clinical signs recur.

Pharmacists are standing by to offer Pet Parent counseling regarding prescription medication purchased from Allivet before and after dispensing. Pharmacists on duty are available Monday-Friday, 9:30AM - 5:30PM EST and will be on call Saturday 12:00PM - 4:00PM EST for consultation.

OSPHOS is administered at 1.8 mg/kg by intramuscular injection up to a maximum dose of 900 mg per horse (one vial). Divide the total volume evenly into three separate injection sites. Discard unused vial contents. OSPHOS is provided in a single use vial and does not contain a preservative.
 
If there is no response to initial therapy, the horse should be re-evaluated. For horses that initially respond to OSPHOS but do not maintain their clinical improvement for 6 months, OSPHOS may be re-administered at 3 to 6 month intervals based on recurrence of clinical signs. For horses that respond to OSPHOS and maintain clinical improvement for 6 months, OSPHOS should be re-administered after clinical signs recur

Osphos intramuscular injection contains the bisphosphonate Clodronic acid

Write a Review

Osphos Inj 60mg/mL, 15 ml

0 Questions 0 Answers
Ask a New Question

Don’t know something or can’t find the information you are looking for? Ask us a question!

*Required Fields
We will ONLY use your email to notify you in regards to your submission.Privacy StatementQuestions & answers are typically posted within 24 hours, pending approval.